HomeInsightsStock Comparison

Jubilant Pharmova Ltd vs Zydus Lifesciences Ltd Stock Comparison

Jubilant Pharmova Ltd vs Zydus Lifesciences Ltd Stock Comparison

Last Updated on: Aug 24, 2025

Key Highlights

  • The Latest Trading Price of Jubilant Pharmova Ltd is ₹ 1081 as of 22 Aug 15:30.
  • The P/E Ratio of Jubilant Pharmova Ltd changed from 4.4 on March 2020 to 16.8 on March 2025 . This represents a CAGR of 25.02% over 6 yearsThe P/E Ratio of Zydus Lifesciences Ltd changed from 23.3 on March 2020 to 19.7 on March 2025 . This represents a CAGR of -2.76% over 6 years.
  • The Market Cap of Jubilant Pharmova Ltd changed from ₹ 3964 crore on March 2020 to ₹ 14220 crore on March 2025 . This represents a CAGR of 23.73% over 6 yearsThe Market Cap of Zydus Lifesciences Ltd changed from ₹ 27344 crore on March 2020 to ₹ 89122 crore on March 2025 . This represents a CAGR of 21.76% over 6 years.
  • The revenue of Jubilant Pharmova Ltd for the Jun '25 is ₹ 1912 crore as compare to the Mar '25 revenue of ₹ 1940 crore. This represent the decline of -1.44% The revenue of Zydus Lifesciences Ltd for the Jun '25 is ₹ 6728 crore as compare to the Mar '25 revenue of ₹ 6608 crore. This represent the growth of 1.82%.
  • The ebitda of Jubilant Pharmova Ltd for the Jun '25 is ₹ 301.5 crore as compare to the Mar '25 ebitda of ₹ 353.9 crore. This represent the decline of -14.81% The ebitda of Zydus Lifesciences Ltd for the Jun '25 is ₹ 2243 crore as compare to the Mar '25 ebitda of ₹ 1986 crore. This represent the growth of 12.93%.
  • The net profit of Jubilant Pharmova Ltd changed from ₹ 6 crore to ₹ 102.5 crore over 9 quarters. This represents a CAGR of 253.03% The net profit of Zydus Lifesciences Ltd changed from ₹ 1112 crore to ₹ 1486 crore over 9 quarters. This represents a CAGR of 13.77% .
  • The Dividend Payout of Jubilant Pharmova Ltd changed from 24.8 % on March 2020 to 414.06 % on March 2025 . This represents a CAGR of 59.87% over 6 yearsThe Dividend Payout of Zydus Lifesciences Ltd changed from 25.37 % on March 2020 to 19.16 % on March 2025 . This represents a CAGR of -4.57% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Jubilant Pharmova Ltd

  • Jubilant Pharmova Limited was initially incorporated as 'Vam Organic Chemicals Limited' on June 21, 1978.
  • The Company name was thereafter changed to 'Jubliant Organosys Limited' in November, 2001 and to 'Jubilant Life Sciences Limited' in October, 2009 and the Company attained its new name 'Jubilant Pharmova Limited' in February, 2021. Jubilant Pharmova Limited is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.
  • The Company is engaged in pharmaceuticals, contract research and development services and proprietary novel drugs.
  • The pharmaceuticals segment, through wholly owned subsidiary Jubilant Pharma Limited, is engaged in manufacture and supply of Active Pharmaceutical Ingredients (APIs), Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Contract Manufacturing of Sterile Injectables and Non-Sterile Products through 6 US FDA approved manufacturing facilities in India, USA and Canada with a network of over 48 radiopharmacies in the USA.

About Zydus Lifesciences Ltd

  • Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain including innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), Active Pharmaceutical Ingredients (APIs), animal healthcare products and consumer wellness products.
  • The Company operate manufacturing facilities at Ahmedabad, Ankleshwar and Vadodara in Gujarat, Ponda in Goa, Raigad in Maharashtra and Solan in Himachal Pradesh. Founded by the Late Promoter, Mr. Ramanbhai B. Patel, the Company was incorporated in May, 1995 and converted into a Public Limited Company in July, 1996.

Jubilant Pharmova Ltd News Hub

News

Jubilant Pharmova AGM scheduled

Jubilant Pharmova announced that the Annual General Meeting(AGM) of the company will be he...

Read more

07 Aug 2025 15:39

News

USFDA concludes pre-approval inspection of Jubilant Generics' Roorkee site

Jubilant Pharmova announced that the United States Food and Drug Administration (USFDA) ha...

Read more

02 Aug 2025 12:47

News

Jubilant Pharmova CFO resigns

Jubilant Pharmova announced the resignation of Arvind Chokhany, Chief Financial Officer & ...

Read more

29 Jul 2025 16:12

News

Jubilant Pharmova schedules board meeting

Jubilant Pharmova will hold a meeting of the Board of Directors of the Company on 29 July ...

Read more

23 Jul 2025 14:56

News

Board of Jubilant Pharmova recommends final dividend

Jubilant Pharmova announced that the Board of Directors of the Company at its meeting held...

Read more

16 May 2025 14:12

News

Jubilant Pharmova jumps after reporting turnaround Q4 performance

Revenue from operations increased 9.7% YoY to Rs 1,915.80 crore in Q4 FY25. The company re...

Read more

16 May 2025 16:07

Zydus Lifesciences Ltd News Hub

News

Zydus Lifesciences receives four observations from USFDA following inspection at Himachal Pradesh facility

According to an exchange filing, the company stated that the USFDA concluded a surveillanc...

Read more

14 Aug 2025 09:34

News

Zydus Lifesciences Ltd gains for third straight session

Zydus Lifesciences Ltd is up for a third straight session today. The stock is quoting at R...

Read more

13 Aug 2025 13:05

News

Zydus Lifesciences gets USDFA approval for Prucalopride tablets

The said drug is equivalent to listed drug Motegrity tablets, 1 mg and 2 mg. Prucalopride ...

Read more

11 Aug 2025 08:23

News

Zydus Lifesciences receives USFDA approval for Prucalopride Tablets

Zydus Lifesciences has received final approval from the United States Food and Drug Admini...

Read more

08 Aug 2025 18:41

News

Zydus receives NOC from Health Canada for ZDS-Varenicline tablets 0.5 &1 mg

Zydus Lifesciences (including its subsidiaries/ affiliates, hereafter referred to as 'Zydu...

Read more

07 Aug 2025 19:17

News

Zydus Lifesciences announces board meeting date

Zydus Lifesciences will hold a meeting of the Board of Directors of the Company on 12 Augu...

Read more

02 Aug 2025 09:52

SWOT Analysis Of Jubilant Pharmova Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Zydus Lifesciences Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

2

T

BlinkX Score for Jubilant Pharmova Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Zydus Lifesciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Jubilant Pharmova Ltd and Zydus Lifesciences Ltd

Which company has a larger market capitalization, Jubilant Pharmova Ltd or Zydus Lifesciences Ltd?

Market cap of Jubilant Pharmova Ltd is 17,223 Cr while Market cap of Zydus Lifesciences Ltd is 99,496 Cr

What are the key factors driving the stock performance of Jubilant Pharmova Ltd and Zydus Lifesciences Ltd?

The stock performance of Jubilant Pharmova Ltd and Zydus Lifesciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Jubilant Pharmova Ltd and Zydus Lifesciences Ltd?

As of August 24, 2025, the Jubilant Pharmova Ltd stock price is INR ₹1081.2. On the other hand, Zydus Lifesciences Ltd stock price is INR ₹988.8.

How do dividend payouts of Jubilant Pharmova Ltd and Zydus Lifesciences Ltd compare?

To compare the dividend payouts of Jubilant Pharmova Ltd and Zydus Lifesciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions